Raymond James Financial Inc Axsome Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 174,586 shares of AXSM stock, worth $19.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
174,586Holding current value
$19.9 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
332Shares Held
38.3MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$478 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$376 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$269 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$119 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.89B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...